News

Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…

With improving patient care a top priority, Sheba recognized technological innovation as an essential enabler of progress and transformation, with a particular emphasis on artificial…

Ulcerative colitis (UC) and Crohn’s disease, the two most common forms of inflammatory bowel disease (IBD), can cause frustrating symptoms like diarrhea, abdominal pain, bloating,…

Non-muscle invasive bladder cancer (NMIBC) develops in the tissue that lines the bladder's inner surface. NMIBC is characterized by a high recurrence rate of up…

A pacemaker, also called a cardiac pacing device, is a small apparatus that's placed (implanted) in the chest to help control the heartbeat by sending…

Peritoneal cancer is a rare malignancy that develops in the peritoneum, a membrane that lines the walls of the abdominal cavity and rests on the…

Zantrene, also known by its generic name bisantrene dihydrochloride, is an anti-cancer drug used both as a low-dose targeted precision oncology agent as well as…

After developing a fever, 4-year-old Maria was brought to the hospital in her native Cyprus by her parents, Nikolas and Ioana. Doctors diagnosed her with…

Headed by Dr. Michael Peled, researcher and attending physician at Sheba’s Institute for Pulmonary Medicine, and Prof. Arie Admon of the Technion – Israel Institute…